Estimation of liver fibrosis by noncommercial serum markers in comparison with transient elastography in patients with chronic hepatitis C virus infection receiving direct ‐acting antiviral treatment

In conclusion, in the present multicentre real‐world cohort, SF and cirrhosis were predicted with high accuracy with noncommercial serum markers using TE as r eference. Further prospective long‐term follow‐up is necessary to compare biomarkers with TE concerning liver‐related outcome and overall mortality.

Source: Journal of Viral Hepatitis - November 8, 2018 Category: Infectious Diseases Authors: Viola Knop, Wolf P. Hofmann, Peter Buggisch, Hartwig Klinker, Stefan Mauss, Rainer G ünther, Holger Hinrichsen, Dietrich Hüppe, Heike Pfeiffer‐Vornkahl, Karl‐Georg Simon, Thomas Berg, Michael P. Manns, Mireen Friedrich‐Rust, German He Tags: ORIGINAL ARTICLE Source Type: research